Peregrine Asset Advisers, Inc. Zoetis Inc. Transaction History

Peregrine Asset Advisers, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$155.97 - $200.09 $701,085 - $899,404	-4,495 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$193.69 - $247.03 $36,413 - $46,441	188 Added 4.36%	4,495 $1.1 Million
Q2 2020 Aug 14, 2020	SELL	$111.92 - $142.53 $116,508 - $148,373	-1,041 Reduced 19.47%	4,307 $590,000
Q1 2020 May 15, 2020	BUY	$92.66 - $144.94 $495,545 - $775,139	5,348 New	5,348 $630,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Peregrine Asset Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Peregrine Asset Advisers, Inc. with notifications on news.